Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.

MacFawn I, Wilson H, Selth LA, Leighton I, Serebriiskii I, Bleackley RC, Elzamzamy O, Farris J, Pifer PM, Richer J, Frisch SM.

Mol Immunol. 2019 Jan;105:137-149. doi: 10.1016/j.molimm.2018.11.006. Epub 2018 Nov 30.

PMID:
30508726
2.

Mechanisms and context underlying the role of autophagy in cancer metastasis.

Dower CM, Wills CA, Frisch SM, Wang HG.

Autophagy. 2018;14(7):1110-1128. doi: 10.1080/15548627.2018.1450020. Epub 2018 Jun 4. Review.

3.

Roles of Grainyhead-like transcription factors in cancer.

Frisch SM, Farris JC, Pifer PM.

Oncogene. 2017 Nov 2;36(44):6067-6073. doi: 10.1038/onc.2017.178. Epub 2017 Jul 17. Review.

PMID:
28714958
4.

Grainyhead-like 2 inhibits the coactivator p300, suppressing tubulogenesis and the epithelial-mesenchymal transition.

Pifer PM, Farris JC, Thomas AL, Stoilov P, Denvir J, Smith DM, Frisch SM.

Mol Biol Cell. 2016 Aug 1;27(15):2479-92. doi: 10.1091/mbc.E16-04-0249. Epub 2016 Jun 1.

5.

Grainyhead-like 2 Reverses the Metabolic Changes Induced by the Oncogenic Epithelial-Mesenchymal Transition: Effects on Anoikis.

Farris JC, Pifer PM, Zheng L, Gottlieb E, Denvir J, Frisch SM.

Mol Cancer Res. 2016 Jun;14(6):528-38. doi: 10.1158/1541-7786.MCR-16-0050. Epub 2016 Apr 15.

6.

CD44S-hyaluronan interactions protect cells resulting from EMT against anoikis.

Cieply B, Koontz C, Frisch SM.

Matrix Biol. 2015 Oct;48:55-65. doi: 10.1016/j.matbio.2015.04.010. Epub 2015 Apr 30.

7.

The wind god promotes lung cancer.

Frisch SM, Schaller MD.

Cancer Cell. 2014 May 12;25(5):551-2. doi: 10.1016/j.ccr.2014.04.022.

8.

Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.

Cieply B, Farris J, Denvir J, Ford HL, Frisch SM.

Cancer Res. 2013 Oct 15;73(20):6299-309. doi: 10.1158/0008-5472.CAN-12-4082. Epub 2013 Aug 13.

9.

Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB.

Park SH, Riley P 4th, Frisch SM.

Apoptosis. 2013 Aug;18(8):949-62. doi: 10.1007/s10495-013-0847-1.

10.

Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis.

Frisch SM, Schaller M, Cieply B.

J Cell Sci. 2013 Jan 1;126(Pt 1):21-9. doi: 10.1242/jcs.120907. Review.

11.

Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2.

Cieply B, Riley P 4th, Pifer PM, Widmeyer J, Addison JB, Ivanov AV, Denvir J, Frisch SM.

Cancer Res. 2012 May 1;72(9):2440-53. doi: 10.1158/0008-5472.CAN-11-4038. Epub 2012 Feb 29.

12.

A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition.

Kumar S, Park SH, Cieply B, Schupp J, Killiam E, Zhang F, Rimm DL, Frisch SM.

Mol Cell Biol. 2011 Oct;31(19):4036-51. doi: 10.1128/MCB.01342-10. Epub 2011 Jul 11.

13.

PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments.

Schaller MD, Frisch SM.

Cancer Biol Ther. 2010 May 15;9(10):791-3. Epub 2010 May 8. No abstract available.

PMID:
20364110
14.

Caspase-8: fly or die.

Frisch SM.

Cancer Res. 2008 Jun 15;68(12):4491-3. doi: 10.1158/0008-5472.CAN-08-0952. Review.

15.
16.

Blockade of tumor necrosis factor-induced Bid cleavage by caspase-resistant Rb.

Huang X, Masselli A, Frisch SM, Hunton IC, Jiang Y, Wang JY.

J Biol Chem. 2007 Oct 5;282(40):29401-13. Epub 2007 Aug 8.

17.

Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions.

Helfer B, Boswell BC, Finlay D, Cipres A, Vuori K, Bong Kang T, Wallach D, Dorfleutner A, Lahti JM, Flynn DC, Frisch SM.

Cancer Res. 2006 Apr 15;66(8):4273-8.

18.

The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.

Bian D, Mahanivong C, Yu J, Frisch SM, Pan ZK, Ye RD, Huang S.

Oncogene. 2006 Apr 6;25(15):2234-44.

PMID:
16301993
20.

Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP.

Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH.

Cell. 2003 Oct 17;115(2):177-86.

21.

Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis.

Screaton RA, Kiessling S, Sansom OJ, Millar CB, Maddison K, Bird A, Clarke AR, Frisch SM.

Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5211-6. Epub 2003 Apr 17.

22.

C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs.

Grooteclaes M, Deveraux Q, Hildebrand J, Zhang Q, Goodman RH, Frisch SM.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4568-73. Epub 2003 Apr 3.

23.

Adenovirus-5 E1A: paradox and paradigm.

Frisch SM, Mymryk JS.

Nat Rev Mol Cell Biol. 2002 Jun;3(6):441-52. Review.

PMID:
12042766
24.

Anoikis mechanisms.

Frisch SM, Screaton RA.

Curr Opin Cell Biol. 2001 Oct;13(5):555-62. Review.

PMID:
11544023
25.
26.

cAMP takes control.

Frisch SM.

Nat Cell Biol. 2000 Sep;2(9):E167-8. Review. No abstract available.

PMID:
10980716
27.

Evidence for a function of CtBP in epithelial gene regulation and anoikis.

Grooteclaes ML, Frisch SM.

Oncogene. 2000 Aug 3;19(33):3823-8.

28.

Anoikis.

Frisch SM.

Methods Enzymol. 2000;322:472-9. No abstract available.

PMID:
10914040
29.
30.

Methods for studying anoikis.

Frisch SM.

Methods Mol Biol. 1999;129:251-6. No abstract available.

PMID:
10494569
31.

Integrins and anoikis.

Frisch SM, Ruoslahti E.

Curr Opin Cell Biol. 1997 Oct;9(5):701-6. Review.

PMID:
9330874
32.

The epithelial cell default-phenotype hypothesis and its implications for cancer.

Frisch SM.

Bioessays. 1997 Aug;19(8):705-9. Review.

PMID:
9264253
33.

The regulation of anoikis: MEKK-1 activation requires cleavage by caspases.

Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM.

Cell. 1997 Jul 25;90(2):315-23.

34.

A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA.

Frisch SM, Vuori K, Kelaita D, Sicks S.

J Cell Biol. 1996 Dec;135(5):1377-82.

35.

Control of adhesion-dependent cell survival by focal adhesion kinase.

Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY.

J Cell Biol. 1996 Aug;134(3):793-9.

36.
37.

Reversal of malignancy by the adenovirus E1a gene.

Frisch SM.

Mutat Res. 1996 Feb 19;350(1):261-6. Review.

PMID:
8657190
38.
39.

E1A--oncogene or tumor suppressor?

Frisch SM.

Bioessays. 1995 Nov;17(11):1002. No abstract available.

PMID:
8526882
41.

E1a induces the expression of epithelial characteristics.

Frisch SM.

J Cell Biol. 1994 Nov;127(4):1085-96.

42.

Disruption of epithelial cell-matrix interactions induces apoptosis.

Frisch SM, Francis H.

J Cell Biol. 1994 Feb;124(4):619-26.

43.

Antioncogenic effect of adenovirus E1A in human tumor cells.

Frisch SM.

Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9077-81.

44.
45.

Secreted proteases. Regulation of their activity and their possible role in metastasis.

Goldberg GI, Frisch SM, He C, Wilhelm SM, Reich R, Collier IE.

Ann N Y Acad Sci. 1990;580:375-84.

PMID:
2159752
46.

Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells.

Frisch SM, Reich R, Collier IE, Genrich LT, Martin G, Goldberg GI.

Oncogene. 1990 Jan;5(1):75-83.

PMID:
2157183
47.
48.

Coordinate regulation of stromelysin and collagenase genes determined with cDNA probes.

Frisch SM, Clark EJ, Werb Z.

Proc Natl Acad Sci U S A. 1987 May;84(9):2600-4.

50.

Supplemental Content

Loading ...
Support Center